Btk inhibitors

Imbruvica resistance provides early but fertile development ground
Imbruvica resistance provides early but fertile development ground
EP Vantage
Arqule
Imbruvica
drug development
Btk inhibitors
Flag link:
In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica
In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica
Endpoints
China
FDA
Btk inhibitors
BeiGene
cancer
Flag link:
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
Endpoints
Eli Lilly
Merck KGaA
Btk inhibitors
autoimmune disease
evobrutinib
Flag link:
$690M deal in peril after Lilly ends mid-stage studies
$690M deal in peril after Lilly ends mid-stage studies
Biopharma Dive
Eli Lilly
clinical trials
rheumatoid arthritis
Btk inhibitors
Hanmi Pharmaceutical
LY3337641/HM71224
Flag link:
Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib
Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib
Endpoints
AstraZeneca
FDA
acalabrutinib
Btk inhibitors
Flag link:
MannKind Rents Out a Drug Program
MannKind Rents Out a Drug Program
Motley Fool
MannKind
Tolero
Btk inhibitors
Flag link:
Pharmacyclics Scores Big With Janssen Biotech Deal
Pharmacyclics Scores Big With Janssen Biotech Deal
Seeking Alpha
Janssen Biotech
Pharmacyclics
Btk inhibitors
Flag link: